Ivermectin and COVID-19: Review of Emerging Evidence 2021
Doctors around the world has been reporting high success rates using an inexpensive anti-parasitic treatment for COVID-19. In April last year, a trial at Melbourne’s Monash University reported doses of ivermectin stopped or slowed the spread of Covid-19 infection in the lab environment. The researchers said the findings could not be immediately applied to humans but the drug still surged in popularity across Peru, Bolivia, Guatemala and other Latin American countries . Another study published in June 2020 by Nature , ivermectin was found to have antiviral activity against a range of viruses including Avian influenza A, Porcine Reproductive and Respiratory Syndrome, HIV, and SARS-Cov-2. The medical community is battling over whether ivermectin should be used to treat and prevent COVID-19. On one side are experts telling you that more research is needed before the treatment can be fully authorised. On the other, are experts telling you that the potential benefits outweigh the risk.